The information contained in Item 4 of the Schedule 13D is hereby amended by adding the following text:
Concurrently with the execution and delivery of an Agreement and Plan of Merger among Sanofi, Vector Merger Sub, Inc. and Translate Bio, Inc., Baupost Group Securities, L.L.C. entered into a Tender and Support Agreement with Sanofi (the “Support Agreement”).
Under the Support Agreement, Baupost Group Securities, L.L.C. agreed to tender into the offer being made by Sanofi for the shares of Translate Bio, Inc., to vote the shares subject to the agreement in favor of matters presented to shareholders which would facilitate the proposed transaction and against matters which would impede the proposed transaction, and to refrain from transferring the shares subject to the agreement other than in certain specified circumstances.
The preceding description of the Support Agreement does not contain a complete description of such agreement and is qualified in its entirety by reference to the full text of the Support Agreement, which is incorporated herein by reference.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)